Clinical Trial Update: Inhaled Sargramostim in Treating Patients With Melanoma Metastatic to the Lung [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating inhaled sargramostim for melanoma metastatic to the lung has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Inhaled Sargramostim (sargramostim)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Melanoma (Skin), Metastatic Cancer | Phase 1 | Status: COMPLETED